SCHEMBL17876210

SCHEMBL17876210

CC1(C)Oc2ccc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)cc2-c2cc(-c3cc(-c4ccccc4)nc(-c4ccccc4)c3)ccc2O1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
MAPT P10636 4/20 0.41
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 2/20 0.41
CYP19A1 P11511 1/20 0.40
MYC P01106 1/20 0.39
ADORA3 P0DMS8 2/20 0.38
ADORA1 P30542 2/20 0.38
ADORA2B P29275 1/20 0.38
MCL1 Q07820 2/20 0.37
ADORA2A P29274 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CTRC Q99895 1/20 0.35
KIF11 P52732 1/20 0.35
PGR P06401 2/20 0.35
CTSD P07339 1/20 0.35
BACE1 P56817 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876215 0.97 KMT2A (0.41) KMT2AMEN1MAPTKDM4EALDH1A1
SCHEMBL17876179 0.95 KMT2A (0.39) KMT2AMEN1MAPTKDM4EALDH1A1
SCHEMBL17876165 0.95 KMT2A (0.39) KMT2AMEN1MAPTKDM4EALDH1A1
SCHEMBL17876176 0.92 MAPT (0.38) KMT2AMEN1MAPTKDM4EALDH1A1
SCHEMBL17876212 0.89 KIF11 (0.41) KMT2AMEN1MAPTKDM4EL3MBTL1
SCHEMBL17876214 0.89 CYP19A1 (0.52) KDM4ECYP19A1PGRCTSDBACE1
SCHEMBL17876197 0.85 HCRTR1 (0.36) KMT2AMEN1MAPTKDM4EALDH1A1
SCHEMBL17876205 0.85 PLA2G2A (0.36) KMT2AMEN1MAPTKDM4EALDH1A1
SCHEMBL17876178 0.85 CYP19A1 (0.48) KDM4EALDH1A1CYP19A1PGRCTSD
SCHEMBL17876175 0.85 CYP19A1 (0.48) KDM4EALDH1A1CYP19A1PGRCTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 KMT2A 1757/4885MEN1 448/4885MAPT 2144/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 KMT2A 1757/4885MEN1 448/4885MAPT 2144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.